Smell function, taste function, and papillae density will decrease in childhood cancer patients during chemotherapy compared to: 1) The period before chemotherapy, 2) Controls (siblings).
ID
Bron
Verkorte titel
Aandoening
Childhood cancer patients
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The main study parameter is feasibility of the study. Therefore we will test whether the lower age range is suitable to be tested. If not, for our next studies we will increase the lower age limit. The number of patients fully completing the study is the main endpoint.
Achtergrond van het onderzoek
Children with cancer experience chemosensory changes (i.e., changes in their sense of taste and smell) during the course of treatment. Irradiation of head and neck, and administration of chemotherapeutic agents induce these changes. This is an often overlooked but still important treatment symptom as it contributes to poor food intake which in turn may cause malnutrition and affect prognosis. The central aim of this project is to elucidate causes and consequences of chemosensory changes in childhood cancer patients. The reasons for examining children with cancer (as opposed to adults) are that (1) there is very little known of the impact cancer treatment has on children’s sense of taste and smell and how this affects food intake and food preferences directly and on the longer term; (2) dietary habits and flavour preferences are still developing in children and thus the impact of therapy induced dysfunctional taste and smell is, presumably, much larger in childhood cancer patients.
Doel van het onderzoek
Smell function, taste function, and papillae density will decrease in childhood cancer patients during chemotherapy compared to: 1) The period before chemotherapy, 2) Controls (siblings).
Onderzoeksopzet
Patients: measurements (smell, taste, papillae density) will take place during clinical admission to the hospital, at least once in every patient.
- Measurement 1: before a cycle of chemotherapy (day 1), in order to explore whether measurements are feasible.
- Measurement 2: at the end of the cycle of chemotherapy, only if the first measurement can be considered as feasible.
Controls: one measurement.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Inclusion criteria patients:
- Children, 6-17 years old
- Currently undergoing chemotherapy
Inclusion criteria controls (siblings):
- Children, 6-17 years old
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Exclusion criteria patients:
- Children with isolated congenital anosmia (ICA; a complete loss of smell)
- Children ≤ 5 years
- Children and parents that do not understand the Dutch language
- Children with a self-reported allergy to quinine
- Children with severe oral mucositis (treatment-induced ulceration of the mucosa, blis-tered tongue, and absence of saliva)
Exclusion criteria controls:
- Children with isolated congenital anosmia (ICA; a complete loss of smell)
- Children ≤ 5 years
- Children and parents that do not understand the Dutch language
- Children with a self-reported allergy to quinine
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7533 |
Ander register | METC UMCG : METC2018/621 |